This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Onkure, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Kevin Hunt - Innovator in HDAC6 Inhibition
Introduction
Kevin Hunt is a notable inventor based in Stephenville, TX (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific biological pathways.
Latest Patents
Kevin Hunt holds a patent for "Benzimidazole compounds as HDAC6 inhibitors." This patent describes novel compounds of Formula I, which are selective HDAC6 inhibitors suitable for the treatment of diseases associated with HDAC6. The compounds are characterized by specific structural elements denoted as X, Y, Z, A, and Q.
Career Highlights
Kevin is currently associated with Onkure, Inc., where he applies his expertise in drug development. His work focuses on creating innovative solutions for complex health issues, particularly those related to cancer and other diseases influenced by HDAC6.
Collaborations
Throughout his career, Kevin has collaborated with talented professionals, including Anthony D. Piscopio and Gan Zhang. These partnerships have enhanced the research and development efforts at Onkure, Inc.
Conclusion
Kevin Hunt's contributions to the field of HDAC6 inhibition exemplify the impact of innovative thinking in medicine. His work continues to pave the way for new therapeutic options in treating diseases linked to HDAC6.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile